A commentary on the safety of probiotics.

Fergus Shanahan

Journal: Gastroenterology clinics of North America 2013;41(4):869-76

PMID: 23101692

Full Text on Elsevier Science View on PubMed

Abstract

Probiotics have a long record of safety, which relates primarily to lactobacilli and bifidobacteria. Experience with other forms of probiotic is more limited. There is no such thing as zero risk, particularly in the context of certain forms of host susceptibility. There is poor public understanding of the concept of risk, in general, and risk/benefit analysis, in particular. Uncertainty persists regarding the potential for transfer of antibiotic resistance with probiotics, but the risk seems to be low with currently available probiotic products. As with other forms of therapeutics, the safety of probiotics should be considered on a strain-by-strain basis.

Address: Department of Medicine, Alimentary Pharmabiotic Centre, University College Cork, National University of Ireland, Galway, Ireland. [email protected]

DOI: 10.1016/j.gtc.2012.08.006

Link outs

Free resources

Research Materials:

https://antibodies.cancer.gov/detail/CPTC-HLA-B-1

Subscription / membership required

Full Text Sources:

MeSH Terms: Drug Resistance, Bacterial, Gastrointestinal Tract, Humans, Obesity, Pancreatitis, Probiotics